ity Health, and the Office on Wom-
en’s Health; and 
‘‘(II) as appropriate, other Fed-
eral departments and agencies the 
programs of which have a significant 
impact upon health. 
‘‘(iv) Private health care payors. 
‘‘(C) RESPONSIBILITIES.—In accordance 
with subsection (b)(5), the board shall— 
‘‘(i) recommend clinical preventive 
services for review by the Task Force; 
‘‘(ii) suggest scientific evidence for 
consideration by the Task Force related to 
reviews undertaken by the Task Force; 
‘‘(iii) provide feedback regarding the 
research plan, the evidence report, and 
draft recommendations by the Task Force; 
and 
‘‘(iv) assist with efforts regarding dis-
semination of recommendations by the Di-
rector of the Agency for Healthcare Re-
search and Quality. 
‘‘(7) DISCLOSURE AND CONFLICTS OF INTER-
EST.—Members of the Task Force or the board shall 
not be considered employees of the Federal Govern-
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H2143.IH
H2143
pwalker on DSK7TPTVN1PROD with BILLS
ment by reason of service on the Task Force or the 
board, except members of the Task Force or the 
board shall be considered to be special Government 
employees within the meaning of section 107 of the 
Ethics in Government Act of 1978 (5 U.S.C. App.) 
and section 208 of title 18, United States Code, for 
the purposes of disclosure and management of con-
flicts of interest under those sections. 
‘‘(8) NO
PAY; 
RECEIPT
OF
TRAVEL
EX-
PENSES.—Members of the Task Force or the board 
shall not receive any pay for service on the Task 
Force or board, but may receive travel expenses, in-
cluding a per diem, in accordance with applicable 
provisions of subchapter I of chapter 57 of title 5, 
United States Code.’’; and 
(7) by amending paragraph (10), as redesig-
nated by paragraph (3), to read as follows: 
‘‘(10) APPLICATION OF FACA.—The Task Force 
shall conduct its activities in compliance with the 
Federal Advisory Committee Act (5 U.S.C. App.).’’. 
(b) EFFECTIVE DATE; TRANSITION.— 
(1) IN
GENERAL.—Except as otherwise pro-
vided, the amendments made by subsection (a) shall 
take effect on the date of the enactment of this Act. 
The United States Preventive Services Task Force 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H2143.IH
H2143
pwalker on DSK7TPTVN1PROD with BILLS
shall not publish any draft or final recommendations 
on or after such date except in accordance with such 
amendments. 
(2) RECONSTITUTION
OF
TASK
FORCE.—Not 
later than 180 days after the date of the enactment 
of this Act, the Director of the Agency for 
Healthcare Research and Quality shall take steps to 
reconstitute the membership of the Task Force con-
sistent with section 915(a)(3) of the Public Health 
Service Act, as amended by subsection (a). 
(3) PREVIOUSLY
PUBLISHED
RECOMMENDA-
TIONS.—With respect to recommendations or guide-
lines published by such Task Force before the date 
of the enactment of this Act, under procedures es-
tablished by the Director of the Agency for 
Healthcare Research and Quality, the reconstituted 
Task Force shall undertake a review process con-
sistent with the following: 
(A) Interested parties may request the 
Task Force to review such previous rec-
ommendations or guidelines. 
(B) Based upon such requests, the Task 
Force shall establish a process for the review of 
previous recommendations or guidelines. 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H2143.IH
H2143
pwalker on DSK7TPTVN1PROD with BILLS
(C) Such process shall include public no-
tice through the Federal Register and oppor-
tunity for comment and a determination to con-
firm or modify such recommendations or guide-
lines. 
(D) The process shall, to the extent fea-
sible, be consistent with the procedures applied 
under the amendments made by subsection (a) 
for the promulgation of new recommendations. 
(c) GAO EVALUATION AND REPORT.—Not later than 
1 year after the date of enactment of this Act, the Comp-
troller General of the United States shall submit to Con-
gress a report that contains the following: 
(1) A listing of the recommendations of the 
United States Preventive Services Task Force as of 
the such date, including the date final recommenda-
tions and any subsequent updates were posted or 
published. 
(2) A comparison of such recommendations and 
relevant recommendations of other Federal health 
agencies, including the Centers for Disease Control 
and Prevention, the Centers for Medicare & Med-
icaid Services, the Department of Defense, the De-
partment of Veterans Affairs, and the Patient-Cen-
tered Outcomes Research Institute, as well as rel-
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H2143.IH
H2143
pwalker on DSK7TPTVN1PROD with BILLS
evant recommendations from national medical pro-
fessional societies and relevant patient and disease 
advocacy organizations. 
(3) An analysis of the impact of the rec-
ommendations of the Task Force on public and pri-
vate insurance coverage, access, and outcomes, in-
cluding impact on morbidity and mortality. 
(d) ELIMINATION OF SECRETARIAL DISCRETION TO 
REMOVE CERTAIN PREVENTIVE SERVICES UNDER THE 
MEDICARE PROGRAM.—Section 1834(n) of the Social Se-
curity Act (42 U.S.C. 1395m(n)), as added by section 
4105(a) of Public Law 111–148, is amended— 
(1) by striking paragraph (2); 
(2) by striking ‘‘; and’’ at the end of paragraph 
(1)(B) and inserting a period; 
(3) by redesignating subparagraphs (A) and 
(B) of paragraph (1) as paragraphs (1) and (2), re-
spectively, and moving their margins 2 ems to the 
left; and 
(4) by striking ‘‘may’’ and all that follows 
through ‘‘modify’’ and inserting ‘‘may modify’’. 
Æ 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6301
E:\BILLS\H2143.IH
H2143
pwalker on DSK7TPTVN1PROD with BILLS